Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Identifieur interne : 000071 ( Ncbi/Checkpoint ); précédent : 000070; suivant : 000072Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Auteurs : Christopher M. Booth [Canada] ; Larissa M. Matukas ; George A. Tomlinson ; Anita R. Rachlis ; David B. Rose ; Hy A. Dwosh ; Sharon L. Walmsley ; Tony Mazzulli ; Monica Avendano ; Peter Derkach ; Issa E. Ephtimios ; Ian Kitai ; Barbara D. Mederski ; Steven B. Shadowitz ; Wayne L. Gold ; Laura A. Hawryluck ; Elizabeth Rea ; Jordan S. Chenkin ; David W. Cescon ; Susan M. Poutanen ; Allan S. DetskySource :
- JAMA [ 0098-7484 ] ; 2003.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analyse de survie, Anti-inflammatoires (usage thérapeutique), Antiviraux (effets indésirables), Antiviraux (usage thérapeutique), Comorbidité, Dyspnée (étiologie), Démographie, Femelle, Fièvre (étiologie), Flambées de maladies, Hospitalisation, Humains, Hydrocortisone (usage thérapeutique), Lutte contre l'infection, Maladies transmissibles émergentes (), Maladies transmissibles émergentes (diagnostic), Maladies transmissibles émergentes (sang), Maladies transmissibles émergentes (épidémiologie), Marqueurs biologiques (sang), Modèles de hasards proportionnels, Mâle, Ontario (épidémiologie), Poumon (imagerie diagnostique), Radiographie, Ribavirine (effets indésirables), Ribavirine (usage thérapeutique), Statistique non paramétrique, Sujet âgé, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (sang), Syndrome respiratoire aigu sévère (épidémiologie), Toux (étiologie), Unités de soins intensifs, Ventilation artificielle, Virus du SRAS (isolement et purification), Études rétrospectives, Évolution de la maladie.
- MESH :
- diagnostic : Maladies transmissibles émergentes, Syndrome respiratoire aigu sévère.
- effets indésirables : Antiviraux, Ribavirine.
- imagerie diagnostique : Poumon.
- isolement et purification : Virus du SRAS.
- sang : Maladies transmissibles émergentes, Marqueurs biologiques, Syndrome respiratoire aigu sévère.
- usage thérapeutique : Anti-inflammatoires, Antiviraux, Hydrocortisone, Ribavirine.
- épidémiologie : Maladies transmissibles émergentes, Ontario, Syndrome respiratoire aigu sévère.
- étiologie : Dyspnée, Fièvre, Toux.
- Adulte, Adulte d'âge moyen, Analyse de survie, Comorbidité, Démographie, Femelle, Flambées de maladies, Hospitalisation, Humains, Lutte contre l'infection, Maladies transmissibles émergentes, Modèles de hasards proportionnels, Mâle, Radiographie, Statistique non paramétrique, Sujet âgé, Syndrome respiratoire aigu sévère, Unités de soins intensifs, Ventilation artificielle, Études rétrospectives, Évolution de la maladie.
English descriptors
- KwdEn :
- Adult, Aged, Anti-Inflammatory Agents (therapeutic use), Antiviral Agents (adverse effects), Antiviral Agents (therapeutic use), Biomarkers (blood), Communicable Diseases, Emerging (blood), Communicable Diseases, Emerging (diagnosis), Communicable Diseases, Emerging (epidemiology), Communicable Diseases, Emerging (therapy), Comorbidity, Cough (etiology), Demography, Disease Outbreaks, Disease Progression, Dyspnea (etiology), Female, Fever (etiology), Hospitalization, Humans, Hydrocortisone (therapeutic use), Infection Control, Intensive Care Units, Lung (diagnostic imaging), Male, Middle Aged, Ontario (epidemiology), Proportional Hazards Models, Radiography, Respiration, Artificial, Retrospective Studies, Ribavirin (adverse effects), Ribavirin (therapeutic use), SARS Virus (isolation & purification), Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (therapy), Statistics, Nonparametric, Survival Analysis.
- MESH :
- chemical , adverse effects : Antiviral Agents, Ribavirin.
- chemical , blood : Biomarkers.
- chemical , therapeutic use : Anti-Inflammatory Agents, Antiviral Agents, Hydrocortisone, Ribavirin.
- blood : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- diagnosis : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- diagnostic imaging : Lung.
- epidemiology : Communicable Diseases, Emerging, Ontario, Severe Acute Respiratory Syndrome.
- etiology : Cough, Dyspnea, Fever.
- isolation & purification : SARS Virus.
- therapy : Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome.
- Adult, Aged, Comorbidity, Demography, Disease Outbreaks, Disease Progression, Female, Hospitalization, Humans, Infection Control, Intensive Care Units, Male, Middle Aged, Proportional Hazards Models, Radiography, Respiration, Artificial, Retrospective Studies, Statistics, Nonparametric, Survival Analysis.
Abstract
Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide.
DOI: 10.1001/jama.289.21.JOC30885
PubMed: 12734147
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003407
- to stream PubMed, to step Curation: 003407
- to stream PubMed, to step Checkpoint: 003301
- to stream Ncbi, to step Merge: 000071
- to stream Ncbi, to step Curation: 000071
Links to Exploration step
pubmed:12734147Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.</title>
<author><name sortKey="Booth, Christopher M" sort="Booth, Christopher M" uniqKey="Booth C" first="Christopher M" last="Booth">Christopher M. Booth</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Mount Sinai Hospital, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Mount Sinai Hospital, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Matukas, Larissa M" sort="Matukas, Larissa M" uniqKey="Matukas L" first="Larissa M" last="Matukas">Larissa M. Matukas</name>
</author>
<author><name sortKey="Tomlinson, George A" sort="Tomlinson, George A" uniqKey="Tomlinson G" first="George A" last="Tomlinson">George A. Tomlinson</name>
</author>
<author><name sortKey="Rachlis, Anita R" sort="Rachlis, Anita R" uniqKey="Rachlis A" first="Anita R" last="Rachlis">Anita R. Rachlis</name>
</author>
<author><name sortKey="Rose, David B" sort="Rose, David B" uniqKey="Rose D" first="David B" last="Rose">David B. Rose</name>
</author>
<author><name sortKey="Dwosh, Hy A" sort="Dwosh, Hy A" uniqKey="Dwosh H" first="Hy A" last="Dwosh">Hy A. Dwosh</name>
</author>
<author><name sortKey="Walmsley, Sharon L" sort="Walmsley, Sharon L" uniqKey="Walmsley S" first="Sharon L" last="Walmsley">Sharon L. Walmsley</name>
</author>
<author><name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name>
</author>
<author><name sortKey="Avendano, Monica" sort="Avendano, Monica" uniqKey="Avendano M" first="Monica" last="Avendano">Monica Avendano</name>
</author>
<author><name sortKey="Derkach, Peter" sort="Derkach, Peter" uniqKey="Derkach P" first="Peter" last="Derkach">Peter Derkach</name>
</author>
<author><name sortKey="Ephtimios, Issa E" sort="Ephtimios, Issa E" uniqKey="Ephtimios I" first="Issa E" last="Ephtimios">Issa E. Ephtimios</name>
</author>
<author><name sortKey="Kitai, Ian" sort="Kitai, Ian" uniqKey="Kitai I" first="Ian" last="Kitai">Ian Kitai</name>
</author>
<author><name sortKey="Mederski, Barbara D" sort="Mederski, Barbara D" uniqKey="Mederski B" first="Barbara D" last="Mederski">Barbara D. Mederski</name>
</author>
<author><name sortKey="Shadowitz, Steven B" sort="Shadowitz, Steven B" uniqKey="Shadowitz S" first="Steven B" last="Shadowitz">Steven B. Shadowitz</name>
</author>
<author><name sortKey="Gold, Wayne L" sort="Gold, Wayne L" uniqKey="Gold W" first="Wayne L" last="Gold">Wayne L. Gold</name>
</author>
<author><name sortKey="Hawryluck, Laura A" sort="Hawryluck, Laura A" uniqKey="Hawryluck L" first="Laura A" last="Hawryluck">Laura A. Hawryluck</name>
</author>
<author><name sortKey="Rea, Elizabeth" sort="Rea, Elizabeth" uniqKey="Rea E" first="Elizabeth" last="Rea">Elizabeth Rea</name>
</author>
<author><name sortKey="Chenkin, Jordan S" sort="Chenkin, Jordan S" uniqKey="Chenkin J" first="Jordan S" last="Chenkin">Jordan S. Chenkin</name>
</author>
<author><name sortKey="Cescon, David W" sort="Cescon, David W" uniqKey="Cescon D" first="David W" last="Cescon">David W. Cescon</name>
</author>
<author><name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
</author>
<author><name sortKey="Detsky, Allan S" sort="Detsky, Allan S" uniqKey="Detsky A" first="Allan S" last="Detsky">Allan S. Detsky</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12734147</idno>
<idno type="pmid">12734147</idno>
<idno type="doi">10.1001/jama.289.21.JOC30885</idno>
<idno type="wicri:Area/PubMed/Corpus">003407</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003407</idno>
<idno type="wicri:Area/PubMed/Curation">003407</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003407</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003301</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003301</idno>
<idno type="wicri:Area/Ncbi/Merge">000071</idno>
<idno type="wicri:Area/Ncbi/Curation">000071</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000071</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.</title>
<author><name sortKey="Booth, Christopher M" sort="Booth, Christopher M" uniqKey="Booth C" first="Christopher M" last="Booth">Christopher M. Booth</name>
<affiliation wicri:level="4"><nlm:affiliation>University of Toronto, Mount Sinai Hospital, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Toronto, Mount Sinai Hospital, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Matukas, Larissa M" sort="Matukas, Larissa M" uniqKey="Matukas L" first="Larissa M" last="Matukas">Larissa M. Matukas</name>
</author>
<author><name sortKey="Tomlinson, George A" sort="Tomlinson, George A" uniqKey="Tomlinson G" first="George A" last="Tomlinson">George A. Tomlinson</name>
</author>
<author><name sortKey="Rachlis, Anita R" sort="Rachlis, Anita R" uniqKey="Rachlis A" first="Anita R" last="Rachlis">Anita R. Rachlis</name>
</author>
<author><name sortKey="Rose, David B" sort="Rose, David B" uniqKey="Rose D" first="David B" last="Rose">David B. Rose</name>
</author>
<author><name sortKey="Dwosh, Hy A" sort="Dwosh, Hy A" uniqKey="Dwosh H" first="Hy A" last="Dwosh">Hy A. Dwosh</name>
</author>
<author><name sortKey="Walmsley, Sharon L" sort="Walmsley, Sharon L" uniqKey="Walmsley S" first="Sharon L" last="Walmsley">Sharon L. Walmsley</name>
</author>
<author><name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name>
</author>
<author><name sortKey="Avendano, Monica" sort="Avendano, Monica" uniqKey="Avendano M" first="Monica" last="Avendano">Monica Avendano</name>
</author>
<author><name sortKey="Derkach, Peter" sort="Derkach, Peter" uniqKey="Derkach P" first="Peter" last="Derkach">Peter Derkach</name>
</author>
<author><name sortKey="Ephtimios, Issa E" sort="Ephtimios, Issa E" uniqKey="Ephtimios I" first="Issa E" last="Ephtimios">Issa E. Ephtimios</name>
</author>
<author><name sortKey="Kitai, Ian" sort="Kitai, Ian" uniqKey="Kitai I" first="Ian" last="Kitai">Ian Kitai</name>
</author>
<author><name sortKey="Mederski, Barbara D" sort="Mederski, Barbara D" uniqKey="Mederski B" first="Barbara D" last="Mederski">Barbara D. Mederski</name>
</author>
<author><name sortKey="Shadowitz, Steven B" sort="Shadowitz, Steven B" uniqKey="Shadowitz S" first="Steven B" last="Shadowitz">Steven B. Shadowitz</name>
</author>
<author><name sortKey="Gold, Wayne L" sort="Gold, Wayne L" uniqKey="Gold W" first="Wayne L" last="Gold">Wayne L. Gold</name>
</author>
<author><name sortKey="Hawryluck, Laura A" sort="Hawryluck, Laura A" uniqKey="Hawryluck L" first="Laura A" last="Hawryluck">Laura A. Hawryluck</name>
</author>
<author><name sortKey="Rea, Elizabeth" sort="Rea, Elizabeth" uniqKey="Rea E" first="Elizabeth" last="Rea">Elizabeth Rea</name>
</author>
<author><name sortKey="Chenkin, Jordan S" sort="Chenkin, Jordan S" uniqKey="Chenkin J" first="Jordan S" last="Chenkin">Jordan S. Chenkin</name>
</author>
<author><name sortKey="Cescon, David W" sort="Cescon, David W" uniqKey="Cescon D" first="David W" last="Cescon">David W. Cescon</name>
</author>
<author><name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
</author>
<author><name sortKey="Detsky, Allan S" sort="Detsky, Allan S" uniqKey="Detsky A" first="Allan S" last="Detsky">Allan S. Detsky</name>
</author>
</analytic>
<series><title level="j">JAMA</title>
<idno type="ISSN">0098-7484</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Anti-Inflammatory Agents (therapeutic use)</term>
<term>Antiviral Agents (adverse effects)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Biomarkers (blood)</term>
<term>Communicable Diseases, Emerging (blood)</term>
<term>Communicable Diseases, Emerging (diagnosis)</term>
<term>Communicable Diseases, Emerging (epidemiology)</term>
<term>Communicable Diseases, Emerging (therapy)</term>
<term>Comorbidity</term>
<term>Cough (etiology)</term>
<term>Demography</term>
<term>Disease Outbreaks</term>
<term>Disease Progression</term>
<term>Dyspnea (etiology)</term>
<term>Female</term>
<term>Fever (etiology)</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Hydrocortisone (therapeutic use)</term>
<term>Infection Control</term>
<term>Intensive Care Units</term>
<term>Lung (diagnostic imaging)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Ontario (epidemiology)</term>
<term>Proportional Hazards Models</term>
<term>Radiography</term>
<term>Respiration, Artificial</term>
<term>Retrospective Studies</term>
<term>Ribavirin (adverse effects)</term>
<term>Ribavirin (therapeutic use)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (blood)</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (therapy)</term>
<term>Statistics, Nonparametric</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Anti-inflammatoires (usage thérapeutique)</term>
<term>Antiviraux (effets indésirables)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Comorbidité</term>
<term>Dyspnée (étiologie)</term>
<term>Démographie</term>
<term>Femelle</term>
<term>Fièvre (étiologie)</term>
<term>Flambées de maladies</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Hydrocortisone (usage thérapeutique)</term>
<term>Lutte contre l'infection</term>
<term>Maladies transmissibles émergentes ()</term>
<term>Maladies transmissibles émergentes (diagnostic)</term>
<term>Maladies transmissibles émergentes (sang)</term>
<term>Maladies transmissibles émergentes (épidémiologie)</term>
<term>Marqueurs biologiques (sang)</term>
<term>Modèles de hasards proportionnels</term>
<term>Mâle</term>
<term>Ontario (épidémiologie)</term>
<term>Poumon (imagerie diagnostique)</term>
<term>Radiographie</term>
<term>Ribavirine (effets indésirables)</term>
<term>Ribavirine (usage thérapeutique)</term>
<term>Statistique non paramétrique</term>
<term>Sujet âgé</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (sang)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Toux (étiologie)</term>
<term>Unités de soins intensifs</term>
<term>Ventilation artificielle</term>
<term>Virus du SRAS (isolement et purification)</term>
<term>Études rétrospectives</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiviral Agents</term>
<term>Ribavirin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term>
<term>Antiviral Agents</term>
<term>Hydrocortisone</term>
<term>Ribavirin</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antiviraux</term>
<term>Ribavirine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Ontario</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cough</term>
<term>Dyspnea</term>
<term>Fever</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Marqueurs biologiques</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Communicable Diseases, Emerging</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term>
<term>Antiviraux</term>
<term>Hydrocortisone</term>
<term>Ribavirine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Maladies transmissibles émergentes</term>
<term>Ontario</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Dyspnée</term>
<term>Fièvre</term>
<term>Toux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Comorbidity</term>
<term>Demography</term>
<term>Disease Outbreaks</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Infection Control</term>
<term>Intensive Care Units</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Proportional Hazards Models</term>
<term>Radiography</term>
<term>Respiration, Artificial</term>
<term>Retrospective Studies</term>
<term>Statistics, Nonparametric</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Comorbidité</term>
<term>Démographie</term>
<term>Femelle</term>
<term>Flambées de maladies</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Lutte contre l'infection</term>
<term>Maladies transmissibles émergentes</term>
<term>Modèles de hasards proportionnels</term>
<term>Mâle</term>
<term>Radiographie</term>
<term>Statistique non paramétrique</term>
<term>Sujet âgé</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Unités de soins intensifs</term>
<term>Ventilation artificielle</term>
<term>Études rétrospectives</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is an emerging infectious disease that first manifested in humans in China in November 2002 and has subsequently spread worldwide.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Avendano, Monica" sort="Avendano, Monica" uniqKey="Avendano M" first="Monica" last="Avendano">Monica Avendano</name>
<name sortKey="Cescon, David W" sort="Cescon, David W" uniqKey="Cescon D" first="David W" last="Cescon">David W. Cescon</name>
<name sortKey="Chenkin, Jordan S" sort="Chenkin, Jordan S" uniqKey="Chenkin J" first="Jordan S" last="Chenkin">Jordan S. Chenkin</name>
<name sortKey="Derkach, Peter" sort="Derkach, Peter" uniqKey="Derkach P" first="Peter" last="Derkach">Peter Derkach</name>
<name sortKey="Detsky, Allan S" sort="Detsky, Allan S" uniqKey="Detsky A" first="Allan S" last="Detsky">Allan S. Detsky</name>
<name sortKey="Dwosh, Hy A" sort="Dwosh, Hy A" uniqKey="Dwosh H" first="Hy A" last="Dwosh">Hy A. Dwosh</name>
<name sortKey="Ephtimios, Issa E" sort="Ephtimios, Issa E" uniqKey="Ephtimios I" first="Issa E" last="Ephtimios">Issa E. Ephtimios</name>
<name sortKey="Gold, Wayne L" sort="Gold, Wayne L" uniqKey="Gold W" first="Wayne L" last="Gold">Wayne L. Gold</name>
<name sortKey="Hawryluck, Laura A" sort="Hawryluck, Laura A" uniqKey="Hawryluck L" first="Laura A" last="Hawryluck">Laura A. Hawryluck</name>
<name sortKey="Kitai, Ian" sort="Kitai, Ian" uniqKey="Kitai I" first="Ian" last="Kitai">Ian Kitai</name>
<name sortKey="Matukas, Larissa M" sort="Matukas, Larissa M" uniqKey="Matukas L" first="Larissa M" last="Matukas">Larissa M. Matukas</name>
<name sortKey="Mazzulli, Tony" sort="Mazzulli, Tony" uniqKey="Mazzulli T" first="Tony" last="Mazzulli">Tony Mazzulli</name>
<name sortKey="Mederski, Barbara D" sort="Mederski, Barbara D" uniqKey="Mederski B" first="Barbara D" last="Mederski">Barbara D. Mederski</name>
<name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
<name sortKey="Rachlis, Anita R" sort="Rachlis, Anita R" uniqKey="Rachlis A" first="Anita R" last="Rachlis">Anita R. Rachlis</name>
<name sortKey="Rea, Elizabeth" sort="Rea, Elizabeth" uniqKey="Rea E" first="Elizabeth" last="Rea">Elizabeth Rea</name>
<name sortKey="Rose, David B" sort="Rose, David B" uniqKey="Rose D" first="David B" last="Rose">David B. Rose</name>
<name sortKey="Shadowitz, Steven B" sort="Shadowitz, Steven B" uniqKey="Shadowitz S" first="Steven B" last="Shadowitz">Steven B. Shadowitz</name>
<name sortKey="Tomlinson, George A" sort="Tomlinson, George A" uniqKey="Tomlinson G" first="George A" last="Tomlinson">George A. Tomlinson</name>
<name sortKey="Walmsley, Sharon L" sort="Walmsley, Sharon L" uniqKey="Walmsley S" first="Sharon L" last="Walmsley">Sharon L. Walmsley</name>
</noCountry>
<country name="Canada"><region name="Ontario"><name sortKey="Booth, Christopher M" sort="Booth, Christopher M" uniqKey="Booth C" first="Christopher M" last="Booth">Christopher M. Booth</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000071 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000071 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Checkpoint |type= RBID |clé= pubmed:12734147 |texte= Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:12734147" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |